Tamoxifen, as one of the selective estrogen receptor modulators (SERM) with tissue-specific activities, is discovered to be a good alternative to clomiphene in women with PCOS and clomiphene-resistant case [64]. The gene discussed is ESR1; the disease is polycystic ovary syndrome.